BeiGene(BGNE)2024-08-29 11:29Financial Reporting - BeiGene, Ltd. filed its 2024 Interim Report for the six months ended June 30, 2024, with the STAR Market of the Shanghai Stock Exchange[3] - The STAR Interim Report includes financial information prepared in accordance with PRC GAAP, which differs from U.S. GAAP[4] - The report contains additional financial data for the Reporting Period, including research and development expenses allocated by key products[4] - The financial information regarding research and development expenses is attached as Exhibit 99.1 to the Current Report[4] - The report was signed by Chan Lee, Senior Vice President and General Counsel of BeiGene, Ltd.[8] Availability - The STAR Interim Report is available in Chinese on the Shanghai Stock Exchange's website[5]